Alpha Tau Medical Ltd. (DRTSW)
NASDAQ: DRTSW · Real-Time Price · USD · Warrants
0.3554
+0.0354 (11.06%)
At close: Dec 5, 2025, 4:00 PM EST
0.3500
-0.0054 (-1.52%)
After-hours: Dec 5, 2025, 4:00 PM EST

Company Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers.

The company is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd.
Alpha Tau Medical logo
CountryIsrael
Founded2015
IndustryBiotechnology
SectorHealthcare
Employees125
CEOUzi Sofer

Contact Details

Address:
Kiryat HaMada St. 5
Jerusalem, 9777605
Israel
Phone972 3 577 4115
Websitealphatau.com

Stock Details

Ticker SymbolDRTSW
ExchangeNASDAQ
Stock TypeWarrants
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001871321
CUSIP NumberM0740A116
ISIN NumberIL0011839466

Key Executives

NamePosition
Uzi SoferChief Executive Officer and Chairman
Raphi LevyChief Financial Officer
Amnon GatChief Operations Officer
Ronen SegalChief Technology Officer
Dr. Robert B. Den M.D.Chief Medical Officer and Member of Scientific Advisory Board
Prof. Yona KeisariChief Scientific Officer and Member of Scientific Advisory board
Rebecca BeckerVice President of legal
Peter M. MelnykChief Commercial Officer
Prof. Itzhak KelsonChief Physics Officer and Member of Scientific Advisory Board
Yael ZeigerCorporate Controller